Federated Hermes’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-27,487
Closed -$209K 2350
2021
Q3
$209K Sell
27,487
-47,513
-63% -$401K ﹤0.01% 1651
2021
Q2
$498K Sell
75,000
-499,756
-87% -$3.15M ﹤0.01% 1512
2021
Q1
$6.96M Buy
+574,756
New +$11.4M 0.01% 762

Other funds holding LHDX

Federated Hermes's LHDX Position: Q4 2021 in Review

Federated Hermes sold out of Lucira Health, Inc. Common Stock (LHDX) in Q4 2021, closing a stake of 27,487 shares — an estimated $209K sold.

Federated Hermes first reported a position in LHDX in Q1 2021 and held it in 3 quarters. The position peaked at $6.96M in Q1 2021. 46 funds tracked by Wall St. Rank hold LHDX as of Q4 2021.

  • Federated Hermes reported no remaining Lucira Health, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Federated Hermes sold 27,487 Lucira Health, Inc. Common Stock shares in Q4 2021, an estimated $209K.
  • Federated Hermes first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Federated Hermes's Lucira Health, Inc. Common Stock position peaked at $6.96M in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q4 2021.

Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.